|
N.V. Sturov, S.V. Popov, Z.A. Ivanov
Disturbances of the gut microbiota and their correction in patients with oxalate nephrolithiasis
|
№14 / 2023
|
|
A.I. Listratov, O.D. Ostroumova, N.L. Lyakhova
Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 2
|
№11-12 / 2022
|
|
A.I. Listratov, O.D. Ostroumova, A.G. Komarova
Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 1
|
№6 / 2022
|
|
A.I. Listratov, O.D. Ostroumova, S.N. Litvinova
Drug-induced kidney stone disease
|
№6 / 2022
|
|
N.K. Dzeranov, L.M. Rapoport, D.G. Tsarichenko
Citrate Metaphylaxis In The Treatment Of Urate Nephrolithiasis
|
№3 / 2013
|
|
A.L. Vertkin 1, A.V. Topolyansky 1,2
Renal Colic
|
№17 / 2012
|
|
E.A. Pronkin
Secondary Prophylaxis Of Urolithiasis
|
№7 / 2012
|
|
Ye.V.Shpot (1), Ye.A. Sultanova (2)
Citrate Therapy For Urolithiasis
|
№4 / 2012
|
|
L.K. Dzeranova, L.M. Rapoport, D.G. Tcarichenko, E.A. Frolova
Litholytic Therapy In Urate Calculus Of Ureter
|
№20 / 2011
|
Русский
